People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spark Therapeutics, Inc. | — | Biotechnology | Series C | $72.8M | $3.0B | 2014 |
Elliott M. Sigal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elliott M. Sigal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven M. Altschuler | 1 | 3 |
| Rogerio M. Vivaldi | 1 | 1 |
| Arthur M. Dantchik | 1 | 1 |
| Joseph W. La Barge | 1 | 1 |
| Jeffrey D. Marrazzo | 1 | 1 |
| Anand M. Mehra | 1 | 1 |
| Lars M. Ekman, M.D. Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.